These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32779007)

  • 1. Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center.
    Cardoso RC; Kamal M; Zaveri J; Chambers MS; Gunn GB; Fuller CD; Lai SY; Mott FE; McMillan H; Hutcheson KA
    Support Care Cancer; 2021 Apr; 29(4):1825-1835. PubMed ID: 32779007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
    ; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
    Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported oral morbidities in long-term oropharyngeal cancer survivors: A cross-sectional survey of 906 survivors.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Oral Oncol; 2018 Sep; 84():88-94. PubMed ID: 30115482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2020 Aug; 149():142-149. PubMed ID: 32387489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.
    Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Lai SY; Fuller CD; Lewin JS; Piller LB; Hutcheson KA
    Head Neck; 2019 Nov; 41(11):3880-3894. PubMed ID: 31441572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Trismus With Quality of Life and Swallowing in Survivors of Head and Neck Cancer.
    Jia Z; Li J; Harrison C; Pawlowicz E; Clump DA; Wasserman-Wincko T; Moore K; Johnson JT; Nilsen ML
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):676-683. PubMed ID: 34253083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).
    Owosho AA; Pedreira Ramalho LM; Rosenberg HI; Yom SK; Drill E; Riedel E; Tsai CJ; Lee NY; Huryn JM; Estilo CL
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1408-13. PubMed ID: 27377999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between trismus and dysphagia-related quality of life in survivors of head and neck cancer in Brazil.
    Ortigara GB; Schulz RE; Soldera EB; Bonzanini LIL; Danesi CC; Antoniazzi RP; Ferrazzo KL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Sep; 128(3):235-242. PubMed ID: 31217081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal patterns of patient-reported trismus and associated mouth-opening distances in radiotherapy for head and neck cancer: A prospective cohort study.
    Thor M; Olsson CE; Oh JH; Hedström J; Pauli N; Johansson M; Deasy JO; Finizia C
    Clin Otolaryngol; 2018 Feb; 43(1):22-30. PubMed ID: 28463432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus.
    Teguh DN; Levendag PC; Voet P; van der Est H; Noever I; de Kruijf W; van Rooij P; Schmitz PI; Heijmen BJ
    Head Neck; 2008 May; 30(5):622-30. PubMed ID: 18213726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced trismus in the ARTSCAN head and neck trial.
    Lindblom U; Gärskog O; Kjellén E; Laurell G; Levring Jäghagen E; Wahlberg P; Zackrisson B; Nilsson P
    Acta Oncol; 2014 May; 53(5):620-7. PubMed ID: 24669774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer.
    Bonzanini LIL; Soldera EB; Ortigara GB; Schulz RE; Antoniazzi RP; Ardenghi TM; Ferrazzo KL
    Support Care Cancer; 2020 Apr; 28(4):1941-1950. PubMed ID: 31375906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
    Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Goepfert RP; Duvall A; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Shete S
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):615-623. PubMed ID: 33956062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
    Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation.
    Karsten RT; Chargi N; van der Molen L; van Son RJJH; de Bree R; Al-Mamgani A; de Boer JP; Hilgers FJM; van den Brekel MWM; Smeele LE; Stuiver MM
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1003-1027. PubMed ID: 34043065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.
    Truong MT; Zhang Q; Rosenthal DI; List M; Axelrod R; Sherman E; Weber R; Nguyen-Tân PF; El-Naggar A; Konski A; Galvin J; Schwartz D; Trotti A; Silverman C; Singh A; Godette K; Bonner JA; Jones CU; Garden AS; Shenouda G; Matthiesen C; Le QT; Bruner D
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):687-699. PubMed ID: 27727066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.
    ; Kamal M; Rosenthal DI; Volpe S; Goepfert RP; Garden AS; Hutcheson KA; Al Feghali KA; Meheissen MAM; Eraj SA; Dursteler AE; Williams B; Smith JB; Aymard JM; Berends J; White AL; Frank SJ; Morrison WH; Cardoso R; Chambers MS; Sturgis EM; Mendoza TR; Lu C; Mohamed ASR; Fuller CD; Gunn GB
    Radiother Oncol; 2018 Jan; 126(1):75-80. PubMed ID: 29229507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited mouth opening after primary therapy of head and neck cancer.
    Weber C; Dommerich S; Pau HW; Kramp B
    Oral Maxillofac Surg; 2010 Sep; 14(3):169-73. PubMed ID: 20358238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a Maxillofacial Oncology clinic.
    Scott B; Butterworth C; Lowe D; Rogers SN
    Oral Oncol; 2008 May; 44(5):430-8. PubMed ID: 17826305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.